Summit Therapeutics Inc. · NASDAQ:SMMT
Zanganeh Mahkam bought 3,810,000 Summit Therapeutics Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 12, 2026
On Jun 12, 2026, Zanganeh Mahkam (Director, Co-Chief Executive Officer, 10% owner) bought 3,810,000 Summit Therapeutics Inc. shares at US$13.12 for US$50M, leaving 573,883,879 shares. Filed Jun 12, 2026 (Form 4).
- Bought
- 3,810,000 shares
- Price
- US$13.12
- Value
- US$50M
- Holding after
- 573,883,879 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Co-Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Buy | 3,810,000 | US$13.12 | 573,883,879 | Indirect |